Those who voted yes reportedly cited "the greater good" and "medical freedom" as reasons for their decisions
Available options include injectable forms, oral capsules, and innovative delivery systems like the ACTIVApatch IontoGo, which combines BPC-157 with other beneficial compounds for extended, convenient treatment
Clinically, BPC-157 is best suited for acute and subacute soft-tissue injuries, including tendon, ligament, muscle, fascia, and periarticular soft-tissue problems
Its like a lot of other things can be going on why somebody has objective improvement in 6 months
Predrag Sikiri, Sven Seiwerth, Ruman, R., Branko Turkovi, Dinko Stani Rokotov, Luka Bri, Sever, M., Kliek, R., Boo Radi, Domagoj Drmi, Spomenko Ili, Kolenc, D., Gorana Aralica, Safic, H., Jelena uran, Rak, D., Senka Didi, Hrvoje Vri, & Boidar ebei